Study Evaluating the Treatment of Occipital Neuralgia
A Prospective Non-Randomized Unblinded Study Evaluating the Treatment of Occipital Neuralgia With the Cryo-Touch III Device
Sponsor: Pacira Pharmaceuticals, Inc
A NA clinical study on Occipital Neuralgia, this trial is completed. The trial is conducted by Pacira Pharmaceuticals, Inc and has accumulated 9 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Feb 2024 — Jul 2024 [monthly]
Completed NA
-
Jul 2023 — Feb 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2023 [monthly]
Completed NA
▶ Show 4 earlier versions
-
Dec 2019 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Dec 2019 [monthly]
Completed NA
-
Feb 2017 — Jun 2018 [monthly]
Completed NA
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
Oct 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Pacira Pharmaceuticals, Inc
For direct contact, visit the study record on ClinicalTrials.gov .